AHA 2023 Insights: The Effect of ARNI With SGLT2 Inhibitor vs ARNI Without SGLT2 Inhibitor on Heart Failure Outcomes in Patients With HFrEF
AHA 2023 Insights: The Effect of ARNI With SGLT2 Inhibitor vs ARNI Without SGLT2 Inhibitor on Heart Failure Outcomes in Patients With HFrEF
A video from Sharath Kommu (as part of AHA 2023 Insights), posted on Nov 21, 2023.
vumedi.com已浏览 416 次2023年11月21日
热门视频
SGLT2 Inhibitor Use in Chronic Kidney Disease
SGLT2 Inhibitor Use in Chronic Kidney Disease
ajmc.com
2021年11月15日
SGLT2 inhibitor found to reduce endothelial dysfunction associated with ALDH2 alcohol face flushing variant
SGLT2 inhibitor found to reduce endothelial dysfunction associated with ALDH2 alcohol face flushing variant
medicalxpress.com
2023年1月26日
Combination Therapy with Metformin and an SGLT2 Inhibitor
Combination Therapy with Metformin and an SGLT2 Inhibitor
diabetesincontrol.com
已浏览 6470 次2022年1月14日
SGLT2 Inhibitors Benefits
Ang mga SGLT2 - inhibitors ay napatunayang mainam sa paggamot ng heart failure o pagpalya ng puso at para mapabagal ang paglala ng chronic kidney disease !!! #diabetes #diabetesawareness #diabetesmanagement #type2diabetes #docirma | Irma Antonio-Pilar MD/ Diabetes and Thyroid Specialist
0:17
Ang mga SGLT2 - inhibitors ay napatunayang mainam sa paggamot ng heart failure o pagpalya ng puso at para mapabagal ang paglala ng chronic kidney disease !!! #diabetes #diabetesawareness #diabetesmanagement #type2diabetes #docirma | Irma Antonio-Pilar MD/ Diabetes and Thyroid Specialist
FacebookIrma Antonio-Pilar MD
已浏览 2.7万 次10 个月之前
🤔 What Are the Newfound Benefits of SGLT2 Inhibitors and GLP-1 Medications? Dr. Jeremy Pettus and Dr. Steve Edelman discuss the benefits of SGLT2 Inhibitors and GLP-1 Medications. Check out what they have to say!🧠 #tcoyd | TCOYD
0:47
🤔 What Are the Newfound Benefits of SGLT2 Inhibitors and GLP-1 Medications? Dr. Jeremy Pettus and Dr. Steve Edelman discuss the benefits of SGLT2 Inhibitors and GLP-1 Medications. Check out what they have to say!🧠 #tcoyd | TCOYD
FacebookTCOYD
已浏览 186 次5 个月之前
2021 ADA Highlights: Landmark DAPA-CKD Trial in Kidney Disease: Extending the Benefits of SGLT2 Inhibitors to and Beyond Diabetic Neuropathy
2021 ADA Highlights: Landmark DAPA-CKD Trial in Kidney Disease: Extending the Benefits of SGLT2 Inhibitors to and Beyond Diabetic Neuropathy
vumedi.com
已浏览 371 次2021年7月14日
SGLT2 Inhibitors Side Effects
eDKA and other adverse effects to SGLT2 inhibitors
eDKA and other adverse effects to SGLT2 inhibitors
dvm360.com
3 个月之前
Important Safety Information - Off-Target Effects of New Therapies for Diabetes: SGLT2 Inhibitors
Important Safety Information - Off-Target Effects of New Therapies for Diabetes: SGLT2 Inhibitors
vumedi.com
已浏览 3194 次6 个月之前
Heterogeneous treatment effects of sodium‐glucose cotransporter 2 inhibitors on risk of dementia in people with type 2 diabetes: A population‐based cohort study » Department of Neurology » College of Medicine » University of Florida
Heterogeneous treatment effects of sodium‐glucose cotransporter 2 inhibitors on risk of dementia in people with type 2 diabetes: A population‐based cohort study » Department of Neurology » College of Medicine » University of Florida
ufl.edu
6 个月之前
反馈